Encanto - The Power of cartilage.

25/08/2025

Orthopaedic Hospital Speising in Vienna, serving as Austria’s exclusive trial site, has started patient recruitment for the ENCANTO clinical study.
Curious to learn more in Austrian German language about how nasal cells could pave the way for cartilage regeneration and improved mobility? Check out the latest details from Krone and OTS, and explore how ENCANTO is reshaping the future of knee therapy.

https://www.ots.at/presseaussendung/OTS_20250807_OTS0022/innovative-arthrose-behandlung-nasenzellen-fuers-knie

https://www.krone.at/3855273

Im Rahmen einer EU-weiten Studie namens ENCANTO wird eine innovative Methode erprobt, bei der Zellen aus der Nase zur Behandlung von Kniearthrosen verwendet werden.

09/08/2025

14/07/2025

We’re live! The ENCANTO Project has officially launched its LinkedIn channel — your new hub for updates on our groundbreaking N‑TEC therapy for regenerating knee cartilage using the body’s own nasal cells.
Follow us here to stay informed on clinical milestones, collaborative breakthroughs, and the people behind this Horizon Europe–funded innovation in osteoarthritis treatment.
👉 https://lnkd.in/dmx3cmvf
hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

Encanto - The Power of Cartilage | 34 followers on LinkedIn. Innovative treatment that repairs damaged cartilage under the kneecap using a special cell therapy. | Encanto (ENgineered CArtilage from Nose for the Treatment of Osteoarthritis) is the latest innovative regenerative treatment that helps r...

04/07/2025

We’re excited to announce the launch of the official ENCANTO Project page!

Follow us to learn how we’re using the body’s own nasal cartilage cells to regenerate knee joints and transform osteoarthritis treatment. Stay up to date with news from our clinical trial, behind-the-scenes moments, and stories from the amazing teams across Europe making it happen.

👍 Like and follow us at facebook.com/encanto.health

Innovative treatment that repairs damaged cartilage under the kneecap using a special cell therapy.